TRIM25 study in people with sepsis
Part of Infections clinical trials.
This trial looks at a protein called TRIM25 in patients with sepsis (a serious infection). It may help doctors understand the condition better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old
- You are currently in the hospital
- You have an infection that has caused a condition called sepsis
- You do not have an immune system disease, like HIV
- You do not have a cancer or long-term viral infection
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether certain biomarkers (substances in your body) can help diagnose sepsis faster. Sepsis is a serious condition where your body has a severe response to an infection. The study will look at blood or other samples to see if these markers can quickly tell if you have sepsis, which could lead to faster treatment.
This study looks at a type of immune cell called 'memory CD8+ T cells' in patients with sepsis, a life-threatening response to infection. The goal is to see if these cells are linked to how severe the sepsis is and the risk of dying. This may help doctors better predict outcomes for people with sepsis.
This trial explores how changes in RNA (a molecule that helps your cells function) might cause long-term immune issues after sepsis, a severe infection. It compares septic patients, critically ill patients without infection, and healthy volunteers to understand these effects.
This study looks at whether certain blood test results can help predict how well people with sepsis will do. Sepsis is a serious infection that can affect the whole body. You may be able to join if you have sepsis and are over 18.
This trial is testing whether a new, highly sensitive blood test (droplet digital PCR) combined with genetic analysis can help doctors predict sepsis earlier in emergency room patients. This could lead to faster treatment and better outcomes.
This trial tests a new blood test called the Sepsis ImmunoScore that may help doctors quickly identify sepsis (a life-threatening infection response). The test looks at your immune system's response to see if you have sepsis, which could help you get treatment faster.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.